Andrew has wide-ranging experience of patent work in all aspects of chemistry. Having an educational background in both general chemistry and chemical physics, Andrew enjoys working with clients whose interests combine chemistry with other technical areas, such as petrochemical and biochemical engineering, electrochemistry, chemical modification of biological molecules including RNA therapeutics and antibodies, medical devices and computational chemistry. He has also worked extensively in the pharmaceutical field, including on commercially important patent portfolios relating to coeliac disease, antibody-based anti-cancer drugs and new delivery systems for local anaesthetics.
Andrew's clients range from university commercialisation bodies and domestic SMEs, through to large national and multinational corporations. Through this broad client base, he has accumulated wide-ranging experience of handling patent drafting and prosecution in Europe and in other established and developing markets throughout the world. He is known for providing easy to follow, pragmatic and commercially-minded advice to companies of all sizes on their IP strategy and portfolio management.
Andrew is listed as an "IP Star" in the Managing Intellectual Property (MIP) IP Stars Handbook and is a ‘recommended individual’ in Who’s Who Legal: Patents.
Andrew joined J A Kemp in 2006 and qualified as a European patent attorney and UK chartered patent attorney in 2010, with the highest marks in several of the examination papers. He became a partner in 2016.
University of Oxford, Masters Degree in Chemistry (Gibbs prize winner for highest first class honours); University of Oxford, DPhil in Physical and Theoretical Chemistry
European Patent Attorney, UK Chartered Patent Attorney
Fellow of the Chartered Institute of Patent Attorneys (CIPA), Member of the Institute of Professional Representatives before the European Patent Office (EPI)